Glenmark Pharmaceuticals Recalls 1.5 Million Bottles of Generic ADHD Drug
by Rishma Parpia

Glenmark Pharmaceuticals, Inc., a subsidiary of Glenmark Pharmaceuticals Ltd. of Mumbai, India, is recalling 1.476 million bottles of a generic Attention Deficit ...
Makers of Experimental COVID-19 Vaccines Lobby EU for Liability Protection
by TVR Staff

Vaccines Europe, a pharmaceutical industry lobbying group, has issued a memo to its member companies saying it would seek liability ...
Novartis Pays $678 Million for Kickbacks to Doctors
by Rishma Parpia

Novartis Pharmaceuticals Corp. of East Hanover, New Jersey has agreed to pay $678 million to settle a civil fraud lawsuit ...
Genetically Engineered Cow Plasma Therapy for COVID-19 Will Be Tested on Humans
by Rishma Parpia

Story Highlights Human trials for a new COVID-19 immunotherapy candidate (SAB-185) that is derived from genetically engineered cow plasma will ...
Rapid Tests for Coronavirus Raise Concerns Over Accuracy
by Marco Cáceres

On Mar. 27, 2020, the U.S. Food and Drug Administration (FDA) issued Emergency Use Authorization (EUA) to pharmaceutical and medical ...
Anti-Depressants in Short Supply During COVID-19 Lockdowns
by Rishma Parpia

Drug shortages listed by the U.S Food and Drug Administration (FDA) are exposing some of the ramifications of responses to ...
Poll Finds Only Half of Americans Plan to Get COVID-19 Vaccine
by TVR Staff

A recent poll conducted by the Associated Press's NORC Center for Public Affairs Research found that 20 percent of Americans ...
COVID-19 Related Drug Shortage in U.S. Because China Supplies Most Ingredients
by Rishma Parpia

Story Highlights The FDA has reported its first drug shortage as a result of the COVID-19 outbreak in China. Many ...
Chinese Pharmaceutical Industry Competes for Vaccine Market Share
by Kate Raines

China’s National Medical Products Administration has announced that two Chinese pharmaceutical companies, Walvax Biotechnology and Innovax, have been approved to ...
In this section
Latest
Popular
Comments
Latest
Popular
Comments
Susan G. on Study of First Next Generation mRNA Bird Flu Shots in Cattle Published
Catt on Novel “Inverse Vaccines” Could Soon Target Autoimmune Diseases
Catt on Novel “Inverse Vaccines” Could Soon Target Autoimmune Diseases
Catt on Novel “Inverse Vaccines” Could Soon Target Autoimmune Diseases
CATT on Study of First Next Generation mRNA Bird Flu Shots in Cattle Published